glp 1 drug novo nordisk Use of GLP-1 drugs early in pregnancy should not cause alarm, analysis suggests Eligible Houston-area Medicare recipients can

Day 35: Ginger reduces gas production

The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for the treatment of obesity

Heres a snapshot of the latest research and what it could mean for the future of food, beverage and consumer demand.

We also describe the development of incretin-based pharmacotherapy, starting with exendin- 4 and ending with the identification of multi-incretin hormone receptor agonists, which appear to be the next major step in the fight against T2DM and obesity

US gut health company Pendulum Therapeutics has introduced Gut Fuel, a doctor-formulated prebiotic fibre and polyphenol powder combining resistant potato starch, baobab, acacia, oat beta-glucan and grape seed extract to support the microbiome, metabolic function and natural GLP-1 pathways